North America Preclinical Imaging Market - Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 16

• 1.1 OBJECTIVES OF THE STUDY 16
• 1.2 MARKET DEFINITION 16
• 1.3 OVERVIEW OF THE NORTH AMERICA PRECLINICAL IMAGING MARKET 16
• 1.4 CURRENCY AND PRICING 18
• 1.5 LIMITATIONS 18
• 1.6 MARKETS COVERED 18

2 MARKET SEGMENTATION 20

• 2.1 MARKETS COVERED 20
• 2.2 GEOGRAPHICAL SCOPE 21
• 2.3 YEARS CONSIDERED FOR THE STUDY 21
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 22
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
• 2.6 MULTIVARIATE MODELLING 26
• 2.7 PRODUCT SEGMENT LIFELINE CURVE 27
• 2.8 MARKET END USER COVERAGE GRID 28
• 2.9 DBMR MARKET POSITION GRID 29
• 2.10 SECONDARY SOURCES 31
• 2.11 ASSUMPTIONS 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 34

• 4.1 PESTEL ANALYSIS 35
• 4.2 PORTER'S FIVE FORCES 36
• 4.3 STRATEGIC INITIATIVES 37

5 REGULATORY FRAMEWORK 38

• 5.1 REGULATORY SCENARIO IN U.S. 38

6 MARKET OVERVIEW 39

• 6.1 DRIVERS 41
  • 6.1.1 INCREASING TECHNOLOGY ADVANCEMENT IN THE FIELD OF IMAGING 41
  • 6.1.2 INCREASING NUMBER OF INVESTMENTS AND FUNDING IN RESEARCH AND DEVELOPMENT 41
  • 6.1.3 INCREASING INCIDENCE OF CHRONIC DISEASES 42
• 6.2 RESTRAINTS 43
  • 6.2.1 STRINGENT REGULATORY FRAMEWORK OR PRODUCT APPROVAL 43
  • 6.2.2 HIGH INSTALLATION AND OPERATIONAL COST OF PRECLINICAL IMAGING SYSTEMS 43
• 6.3 OPPORTUNITIES 44
  • 6.3.1 INCREASING ADOPTION OF IMAGING SYSTEMS FOR PRECLINICAL PURPOSE 44
  • 6.3.2 GROWING DEMAND FOR NON-INVASIVE SMALL-ANIMAL IMAGING METHODS 44
• 6.4 CHALLENGES 45
  • 6.4.1 LACK OF SKILLED PROFESSIONALS FOR THE EFFECTIVE UTILIZATION OF PRECLINICAL IMAGING SYSTEMS 45
  • 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 45

7 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY PRODUCT 47

• 7.1 OVERVIEW 48
• 7.2 SYSTEMS 51
  • 7.2.1 OPTICAL IMAGING SYSTEMS 52
    • 7.2.1.1 BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS 52
    • 7.2.1.2 STANDALONE FLUORESCENCE IMAGING SYSTEMS 52
    • 7.2.1.3 OPTICAL + X-RAY/OPTICAL + CT 52
  • 7.2.2 PRECLINICAL NUCLEAR IMAGING SYSTEMS 53
    • 7.2.2.1 MICRO-POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS 53
    • 7.2.2.2 MICRO-SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SYSTEMS 53
    • 7.2.2.3 TRIPRODUCT (SPECT/PET/CT) SYSTEMS 53
  • 7.2.3 MICRO-MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 53
  • 7.2.4 MICRO-COMPUTED TOMOGRAPHY (CT) SYSTEMS 53
  • 7.2.5 MICRO-ULTRASOUND SYSTEMS 54
  • 7.2.6 PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS 54
  • 7.2.7 PRECLINICAL MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS 54
  • 7.2.8 MAGNETIC RESONANCE SPECTROSCOPY IMAGING (MRSI) 54
• 7.3 SERVICES 54

8 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS 55

• 8.1 OVERVIEW 56
• 8.2 PRECLINICAL OPTICAL IMAGING REAGENTS 59
  • 8.2.1 BIOLUMINESCENT IMAGING REAGENTS 59
  • 8.2.2 FLUORESCENT IMAGING REAGENTS 59
• 8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS 59
  • 8.3.1 PRECLINICAL PET TRACERS 60
  • 8.3.2 PRECLINICAL SPECT PROBES 60
• 8.4 PRECLINICAL MRI CONTRAST AGENTS 60
  • 8.4.1 GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS 60
  • 8.4.2 MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS 60
  • 8.4.3 IRON-BASED PRECLINICAL MRI CONTRAST AGENTS 60
• 8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS 61

• 8.6 PRECLINICAL CT CONTRAST AGENTS 61
  • 8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS 61
  • 8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS 61
  • 8.6.3 GOLD NANOPARTICLES 61
  • 8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS 61

9 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY APPLICATION 62

• 9.1 OVERVIEW 63
• 9.2 RESEARCH AND DEVELOPMENT 66
• 9.3 DRUG DISCOVERY 66
• 9.4 BIO-DISTRIBUTION 66
• 9.5 CANCER CELL DETECTION 66
• 9.6 BIO-MARKERS 66
• 9.7 OTHERS 66

10 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY END USER 67

• 10.1 OVERVIEW 68
• 10.2 CONTRACT RESEARCH ORGANIZATION 71
• 10.3 PHARMACEUTICAL & BIOTECH COMPANIES 71
• 10.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 71
• 10.5 DIAGNOSTICS CENTER 71
• 10.6 OTHERS 71

11 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY COUNTRY 72

• 11.1 NORTH AMERICA 72
  • 11.1.1 U.S. 74
  • 11.1.2 CANADA 83
  • 11.1.3 MEXICO 92

12 NORTH AMERICA PRECLINICAL IMAGING MARKET, COMPANY LANDSCAPE 101

• 12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 101

13 SWOT ANALYSIS 102

14 COMPANY PROFILE 103

• 14.1 PERKINELMER INC. 103
  • 14.1.1 COMPANY SNAPSHOT 103
  • 14.1.2 REVENUE ANALYSIS 103
  • 14.1.3 PRODUCT PORTFOLIO 104
  • 14.1.4 RECENT DEVELOPMENT 105

• 14.2 FUJIFILM VISUALSONICS, INC 106
  • 14.2.1 COMPANY SNAPSHOT 106
  • 14.2.2 REVENUE ANALYSIS 106
  • 14.2.3 PRODUCT PORTFOLIO 107
  • 14.2.4 RECENT DEVELOPMENT 107
• 14.3 BRUKER 108
  • 14.3.1 COMPANY SNAPSHOT 108
  • 14.3.2 REVENUE ANALYSIS 108
  • 14.3.3 PRODUCT PORTFOLIO 109
  • 14.3.4 RECENT DEVELOPMENT 109
• 14.4 HOLOGIC, INC. 110
  • 14.4.1 COMPANY SNAPSHOT 110
  • 14.4.2 REVENUE ANALYSIS 110
  • 14.4.3 PRODUCT PORTFOLIO 111
  • 14.4.4 RECENT DEVELOPMENT 111
• 14.5 AGILENT TECHNOLOGIES, INC. 112
  • 14.5.1 COMPANY SNAPSHOT 112
  • 14.5.2 REVENUE ANALYSIS 112
  • 14.5.3 PRODUCT PORTFOLIO 113
  • 14.5.4 RECENT DEVELOPMENT 113
• 14.6 AI4R 114
  • 14.6.1 COMPANY SNAPSHOT 114
  • 14.6.2 PRODUCT PORTFOLIO 114
  • 14.6.3 RECENT DEVELOPMENT 114
• 14.7 ASPECT IMAGING LTD. 115
  • 14.7.1 COMPANY SNAPSHOT 115
  • 14.7.2 PRODUCT PORTFOLIO 115
  • 14.7.3 RECENT DEVELOPMENT 115
• 14.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG 116
  • 14.8.1 COMPANY SNAPSHOT 116
  • 14.8.2 PRODUCT PORTFOLIO 116
  • 14.8.3 RECENT DEVELOPMENT 116
• 14.9 CUBRESA INC. 117
  • 14.9.1 COMPANY SNAPSHOT 117
  • 14.9.2 PRODUCT PORTFOLIO 117
  • 14.9.3 RECENT DEVELOPMENT 117
• 14.10 HAMAMATSU PHOTONICS K.K. 118
  • 14.10.1 COMPANY SNAPSHOT 118
  • 14.10.2 REVENUE ANALYSIS 118
  • 14.10.3 PRODUCT PORTFOLIO 119
  • 14.10.4 RECENT DEVELOPMENT 119
• 14.11 IVIM TECHNOLOGY CORP. 120
  • 14.11.1 COMPANY SNAPSHOT 120
  • 14.11.2 PRODUCT PORTFOLIO 120
  • 14.11.3 RECENT DEVELOPMENT 120
• 14.12 KUB TECHNOLOGES INC. 121
  • 14.12.1 COMPANY SNAPSHOT 121
  • 14.12.2 PRODUCT PORTFOLIO 121
  • 14.12.3 RECENT DEVELOPMENT 121
• 14.13 LI-COR, INC. 122
  • 14.13.1 COMPANY SNAPSHOT 122
  • 14.13.2 PRODUCT PORTFOLIO 122
  • 14.13.3 RECENT DEVELOPMENT 122
• 14.14 MEDISO LTD. 123
  • 14.14.1 COMPANY SNAPSHOT 123
  • 14.14.2 PRODUCT PORTFOLIO 123
  • 14.14.3 RECENT DEVELOPMENT 123
• 14.15 MILABS B.V. 124
  • 14.15.1 COMPANY SNAPSHOT 124
  • 14.15.2 PRODUCT PORTFOLIO 124
  • 14.15.3 RECENT DEVELOPMENT 124
• 14.16 MR SOLUTIONS 125
  • 14.16.1 COMPANY SNAPSHOT 125
  • 14.16.2 PRODUCT PORTFOLIO 125
  • 14.16.3 RECENT DEVELOPMENT 125
• 14.17 PHOTON ETC 126
  • 14.17.1 COMPANY SNAPSHOT 126
  • 14.17.2 PRODUCT PORTFOLIO 126
  • 14.17.3 RECENT DEVELOPMENT 126
• 14.18 SOFIE 127
  • 14.18.1 COMPANY SNAPSHOT 127
  • 14.18.2 PRODUCT PORTFOLIO 127
  • 14.18.3 RECENT DEVELOPMENT 127
• 14.19 TRIFOIL IMAGING 128
  • 14.19.1 COMPANY SNAPSHOT 128
  • 14.19.2 PRODUCT PORTFOLIO 128
  • 14.19.3 RECENT DEVELOPMENT 128 
• 14.20 VIEWORKS CO., LTD. 129
  • 14.20.1 COMPANY SNAPSHOT 129
  • 14.20.2 REVENUE ANALYSIS 129
  • 14.20.3 PRODUCT PORTFOLIO 130
  • 14.20.4 RECENT DEVELOPMENT 130
• 14.21 ZEISS INTERNATIONAL 131
  • 14.21.1 COMPANY SNAPSHOT 131
  • 14.21.2 REVENUE ANALYSIS 131
  • 14.21.3 PRODUCT PORTFOLIO 132
  • 14.21.4 RECENT DEVELOPMENTS 132

15 QUESTIONNAIRE 133

16 RELATED REPORTS 136

LIST OF TABLES

• TABLE 1 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 50
• TABLE 2 NORTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 51
• TABLE 3 NORTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 52
• TABLE 4 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 53
• TABLE 5 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 58
• TABLE 6 NORTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 59
• TABLE 7 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 59
• TABLE 8 NORTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 60
• TABLE 9 NORTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 61
• TABLE 10 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 65
• TABLE 11 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 70
• TABLE 12 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 73
• TABLE 13 U.S. PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 74
• TABLE 14 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 74
• TABLE 15 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 75
• TABLE 16 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 75
• TABLE 17 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 76
• TABLE 18 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 76
• TABLE 19 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 76
• TABLE 20 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 77
• TABLE 21 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 77
• TABLE 22 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 77
• TABLE 23 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 78
• TABLE 24 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 78
• TABLE 25 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 78
• TABLE 26 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 79
• TABLE 27 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 79
• TABLE 28 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 79
• TABLE 29 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 79
• TABLE 30 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 80
• TABLE 31 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 80
• TABLE 32 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 80
• TABLE 33 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 80
• TABLE 34 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 81
• TABLE 35 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 81
• TABLE 36 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 81
• TABLE 37 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 82
• TABLE 38 U.S. PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 82
• TABLE 39 U.S. PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 82
• TABLE 40 CANADA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 83
• TABLE 41 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 83
• TABLE 42 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 84
• TABLE 43 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 84
• TABLE 44 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 85
• TABLE 45 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 85
• TABLE 46 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 85
• TABLE 47 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 86
• TABLE 48 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 86
• TABLE 49 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 86
• TABLE 50 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 87
• TABLE 51 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 87
• TABLE 52 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 87
• TABLE 53 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 88
• TABLE 54 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 88
• TABLE 55 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 88
• TABLE 56 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 88
• TABLE 57 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 89
• TABLE 58 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 89
• TABLE 59 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 89
• TABLE 60 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 89
• TABLE 61 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 90
• TABLE 62 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 90
• TABLE 63 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 90
• TABLE 64 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 91
• TABLE 65 CANADA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 91
• TABLE 66 CANADA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 91
• TABLE 67 MEXICO PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 92
• TABLE 68 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 92
• TABLE 69 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 93
• TABLE 70 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 93
• TABLE 71 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 94
• TABLE 72 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 94
• TABLE 73 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 94
• TABLE 74 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 94
• TABLE 75 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 95
• TABLE 76 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 95
• TABLE 77 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 95
• TABLE 78 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 96
• TABLE 79 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 96
• TABLE 80 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 96
• TABLE 81 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 96
• TABLE 82 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 97
• TABLE 83 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 97
• TABLE 84 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 97
• TABLE 85 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 97
• TABLE 86 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 98
• TABLE 87 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 98
• TABLE 88 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 98
• TABLE 89 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 99
• TABLE 90 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 99
• TABLE 91 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 100
• TABLE 92 MEXICO PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 100
• TABLE 93 MEXICO PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 100

LIST OF FIGURES

• FIGURE 1 NORTH AMERICA PRECLINICAL IMAGING MARKET: SEGMENTATION 20
• FIGURE 2 NORTH AMERICA PRECLINICAL IMAGING MARKET: DATA TRIANGULATION 22
• FIGURE 3 NORTH AMERICA PRECLINICAL IMAGING MARKET: DROC ANALYSIS 23
• FIGURE 4 NORTH AMERICA PRECLINICAL IMAGING MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 24
• FIGURE 5 NORTH AMERICA PRECLINICAL IMAGING MARKET: COMPANY RESEARCH ANALYSIS 24
• FIGURE 6 NORTH AMERICA PRECLINICAL IMAGING MARKET: INTERVIEW DEMOGRAPHICS 25
• FIGURE 7 NORTH AMERICA PRECLINICAL IMAGING MARKET: MARKET END USERS COVERAGE GRID 28
• FIGURE 8 NORTH AMERICA PRECLINICAL IMAGING MARKET: DBMR MARKET POSITION GRID 29
• FIGURE 9 NORTH AMERICA PRECLINICAL IMAGING MARKET: SEGMENTATION 33
• FIGURE 10 RISING PREVALENCE OF CHRONIC DISORDER AND ADVANCEMENTS IN IMAGING TECHNIQUES ARE EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA PRECLINICAL IMAGING MARKET FROM 2023 TO 2030 34
• FIGURE 11 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PRECLINICAL MARKET IN 2023 AND 2030 34
• FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA PRECLINICAL IMAGING MARKET 40
• FIGURE 13 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY PRODUCT, 2022 48
• FIGURE 14 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 49
• FIGURE 15 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY PRODUCT, CAGR (2023-2030) 49
• FIGURE 16 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY PRODUCT, LIFELINE CURVE 50
• FIGURE 17 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY REAGENTS, 2022 56
• FIGURE 18 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY REAGENTS, 2023-2030 (USD THOUSAND) 57
• FIGURE 19 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY REAGENTS, CAGR (2023-2030) 57
• FIGURE 20 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY REAGENTS, LIFELINE CURVE 58
• FIGURE 21 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY APPLICATION, 2022 63
• FIGURE 22 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 64
• FIGURE 23 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY APPLICATION, CAGR (2023-2030) 64
• FIGURE 24 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY APPLICATION, LIFELINE CURVE 65
• FIGURE 25 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY END USER, 2022 68
• FIGURE 26 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 69
• FIGURE 27 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY END USER, CAGR (2023-2030) 69
• FIGURE 28 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY END USER, LIFELINE CURVE 70
• FIGURE 29 NORTH AMERICA PRECLINICAL IMAGING MARKET: BY SNAPSHOT (2022) 72
• FIGURE 30 NORTH AMERICA PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 101